Gene · 5696
Papers2,476
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,476
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antiviral CD8+ T-cell immune responses are impaired by cigarette smoke and in COPD. | Eur Respir J | 2023 | 37385655 | PubTator, text mining | PubMed |
| Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition. | Sci Adv | 2023 | 37379383 | PubTator, text mining | PubMed |
| Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis. | Int J Mol Sci | 2023 | 37373215 | PubTator, text mining | PubMed |
| Loss of PRDX6 Aborts Proliferative and Migratory Signaling in Hepatocarcinoma Cell Lines. | Antioxidants (Basel) | 2023 | 37371884 | PubTator, text mining | PubMed |
| Unpacking the Complexity of Epithelial Plasticity: From Master Regulator Transcription Factors to Non-Coding RNAs. | Cancers (Basel) | 2023 | 37370762 | PubTator, text mining | PubMed |
| Phosphomevalonate kinase deficiency expands the genetic spectrum of systemic autoinflammatory diseases. | J Allergy Clin Immunol | 2023 | 37364720 | PubTator, text mining | PubMed |
| Bioinformatic analysis of gene expression data reveals Src family protein tyrosine kinases as key players in androgenetic alopecia. | Front Med (Lausanne) | 2023 | 37359019 | PubTator, text mining | PubMed |
| Quantitative measurement of the requirement of diverse protein degradation pathways in MHC class I peptide presentation. | Sci Adv | 2023 | 37352349 | PubTator, text mining | PubMed |
| Interplay between proteasome function and inflammatory responses in e-cig vapor condensate-challenged lung epithelial cells. | Arch Toxicol | 2023 | 37344694 | PubTator, text mining | PubMed |
| Proteomic analysis to identification of hypoxia related markers in spinal tuberculosis: a study based on weighted gene co-expression network analysis and machine learning. | BMC Med Genomics | 2023 | 37340462 | PubTator, text mining | PubMed |
| Short chain fatty acids prime colorectal cancer cells to activate antitumor immunity. | Front Immunol | 2023 | 37304266 | PubTator, text mining | PubMed |
| Signaling pathways and intervention for therapy of type 2 diabetes mellitus. | MedComm (2020) | 2023 | 37303813 | PubTator, text mining | PubMed |
| Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease. | Int J Mol Sci | 2023 | 37298547 | PubTator, text mining | PubMed |
| Insights into anti-tumor immunity via the polyomavirus shared across human Merkel cell carcinomas. | Front Immunol | 2023 | 37287968 | PubTator, text mining | PubMed |
| ZNF655 promotes the progression of hepatocellular carcinoma through PSMB8. | Cell Biol Int | 2023 | 37272200 | PubTator, text mining | PubMed |
| Gastric cancer cell types display distinct proteasome/immunoproteasome patterns associated with migration and resistance to proteasome inhibitors. | J Cancer Res Clin Oncol | 2023 | 37261527 | PubTator, text mining | PubMed |
| PSMC3 proteasome subunit variants are associated with neurodevelopmental delay and type I interferon production. | Sci Transl Med | 2023 | 37256937 | PubTator, text mining | PubMed |
| The dichotomous role of immunoproteasome in cancer: Friend or foe? | Acta Pharm Sin B | 2023 | 37250147 | PubTator, text mining | PubMed |
| Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients' Induced Pluripotent Stem-Cell-Derived Cardiomyocytes. | Int J Mol Sci | 2023 | 37240001 | PubTator, text mining | PubMed |
| PD-L1: expression regulation. | Blood Sci | 2023 | 37228770 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5696/papers?page=11